ACCELERATE DS-812

ACCELERATE DS-812 is a modified cellulose gum that can be used in the pharmaceutical industry. ACCELERATE DS-812 meets the requirements for residual solvents in the United States Pharmacopeia and complies with the ICH Guide Q3C for residual solvents. It has a degree of substitution of 0.65-0.95 and loss on drying of NMT 6% making it suitable for use in pharmaceutical applications. ACCELERATE DS-812 provides benefits such as viscosity control and suspension properties which are important for various pharmaceutical dosage forms. Its hygroscopic nature allows for controlled drug release and helps maintain the integrity of active pharmaceutical ingredients.